Monotherapeutic High-Dose-Rate Brachytherapy for Prostate Cancer: Five-Year Results of an Extreme Hypofractionation Regimen With 54 Gy in Nine Fractions-Reference-Cited by-同舟云学术

Monotherapeutic High-Dose-Rate Brachytherapy for Prostate Cancer: Five-Year Results of an Extreme Hypofractionation Regimen With 54 Gy in Nine Fractions

Published:2011-06 Issue:2 Volume:80 Page:469-475
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Yoshioka Yasuo,Konishi Koji,Sumida Iori,Takahashi Yutaka,Isohashi Fumiaki,Ogata Toshiyuki,Koizumi Masahiko,Yamazaki Hideya,Nonomura Norio,Okuyama Akihiko,Inoue Takehiro

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference36 articles.

1. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer;Nag;Int J Radiat Oncol Biol Phys,1999

2. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer;Ash;Radiother Oncol,2000

3. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer;Galalae;Int J Radiat Oncol Biol Phys,2002

4. Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma;Borghede;Radiother Oncol,1997

5. High dose-rate afterloading Ir-192 prostate brachytherapy: Feasibility report;Mate;Int J Radiat Oncol Biol Phys,1998

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AAPM Task Group Report 267: A joint AAPM GEC‐ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapy;Medical Physics;2024-05-09

2. A comparative study of patient-reported outcomes after contemporary radiation techniques for prostate cancer;Radiotherapy and Oncology;2022-06

3. Ultrahypofractionated Radiotherapy for Localised Prostate Cancer: How Far Can We Go?;Clinical Oncology;2021-12

4. High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome;Cancer Reports;2021-06-23

5. High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center;Journal of Contemporary Brachytherapy;2021